Cost-effectiveness of adult pneumococcal vaccination: responding to: Weycker D, Sato R, Strutton D, Edelsberg J, Atwood M, Jackson LA. Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years. Vaccine 2012;30(August (36)):5437-44.
| Autor: | Grabenstein JD, O'Brien MA, Chen J |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Vaccine [Vaccine] 2013 Mar 15; Vol. 31 (12), pp. 1549. Date of Electronic Publication: 2012 Nov 12. |
| DOI: | 10.1016/j.vaccine.2012.10.110 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect